CoChat

Diabetes Remission Status During Seven-year Follow-up of the Longitudinal Assessment of Bariatric Surgery Study

Open access
Purnell, Jonathan Q, Dewey, Elizabeth N, Laferrère, Blandine, Selzer, Faith, Flum, David R, Mitchell, James E, Pomp, Alfons, Pories, Walter J, Inge, Thomas, Courcoulas, Anita, Wolfe, Bruce M · 2021 · The Journal of Clinical Endocrinology & Metabolism
Cited by 66

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Context: Few studies have examined the clinical characteristics that predict durable, long-term diabetes remission after bariatric surgery. Objective: To compare diabetes prevalence and remission rates during 7-year follow-up after Roux-en-Y gastric bypass (RYGB) and laparoscopic gastric banding (LAGB). Design: An observational cohort of adults with severe obesity recruited between 2006 and 2009 who completed annual research assessments for up to 7 years after RYGB or LAGB. Setting: Ten US hospitals. Participants: A total sample of 2256 participants, 827 with known diabetes status at both baseline and at least 1 follow-up visit. Interventions: Roux-en-Y gastric bypass or LAGB. Main Outcome Measures: Diabetes rates and associations of patient characteristics with remission status. Results: Diabetes remission occurred in 57% (46% complete, 11% partial) after RYGB and 22.5% (16.9% complete, 5.6% partial) after LAGB. Following both procedures, remission was greater in younger participants and those with shorter diabetes duration, higher C-peptide levels, higher homeostatic model assessment of β-cell function (HOMA %B), and lower insulin usage at baseline, and with greater postsurgical weight loss. After LAGB, reduced HOMA insulin resistance (IR) was associated with a greater likelihood of diabetes remission, whereas increased HOMA-%B predicted remission after RYGB. Controlling for weight lost, diabetes remission remained nearly 4-fold higher compared with LAGB. Conclusions: Durable, long-term diabetes remission following bariatric surgery is more likely when performed soon after diagnosis when diabetes medication burden is low and beta-cell function is preserved. A greater weight-independent likelihood of diabetes remission after RYGB than LAGB suggests mechanisms beyond weight loss contribute to improved beta-cell function after RYGB. Trial Registration clinicaltrials.gov Identifier: NCT00465829.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgaa849

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 66

Metadata

Authors
Purnell, J. Q., Dewey, E. N., Laferrère, B., Selzer, F., Flum, D. R., Mitchell, J. E., Pomp, A., Pories, W. J., Inge, T., Courcoulas, A., & Wolfe, B. M.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2020-11-25
Volume
106
Issue
3
Pages
774-788
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3109759785
Cited by
66
References
20
FWCI
8.01
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diabetes Remission Status During Seven-year Follow-up of the Longitudinal Assessment of Bariatric Surgery Study. https://app.cochat.ai/papers/10.1210/clinem/dgaa849
The paper
Purnell, J. Q., Dewey, E. N., Laferrère, B., Selzer, F., Flum, D. R., Mitchell, J. E., Pomp, A., Pories, W. J., Inge, T., Courcoulas, A., & Wolfe, B. M. (2021). Diabetes Remission Status During Seven-year Follow-up of the Longitudinal Assessment of Bariatric Surgery Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaa849

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.